Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03496844 · ClinicalTrials.gov registry record · NA

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT03496844 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03496844, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Determine diagnostic accuracy of Axumin-PET positive bone lesion by confirmatory bone biopsy.

Interventions

  • DIAGNOSTIC_TEST F-18 fluciclovine-PET/CT scan

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-04-15
Est. Completion 2021-04-27
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03496844

The ClinicalTrials.gov registry entry for NCT03496844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which F-18 fluciclovine-PET/CT scan is the first listed.

NCT03496844 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03496844 about?

NCT03496844 is a clinical study titled "Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma". Determine diagnostic accuracy of Axumin-PET positive bone lesion by confirmatory bone biopsy.

What is the current status of trial NCT03496844?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-04-15. Estimated completion is 2021-04-27.

What interventions are being tested in trial NCT03496844?

The interventions under investigation include: F-18 fluciclovine-PET/CT scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03496844?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.